High-Level Steering Group for
Every Woman Every Child
To help provide leadership and inspire ambitious action for women’s, children’s and adolescents’ health, as well as encourage collaboration and integration with relevant areas of the 2030 Agenda for Sustainable Development, the UN Secretary-General established a High-level Advisory Group for Every Woman Every Child.
The group is co-chaired by H.E. Ms. Kersti Kaljulai, President of the Estonia and there are two alternate co-chairs, H.E. Ms. Tarja Halonen, former President of the Republic of Finland, and H.E. Mr. Jakaya Mrisho Kikwete, former President of the United Republic of Tanzania.
The members were drawn to include global representation from governments, the business community, philanthropists, young people, civil society and multilateral systems, and reflect the diversity of the Every Woman Every Child movement.
The initial members announced in January 2016 were expanded to include additional key leaders. With initial appointments lasting for one year, the group meets to review progress and challenges, and provide recommendations on issues such as financing, accountability, cross-sectoral action and country-level implementation of the Every Woman Every Child Global Strategy for Women’s, Children’s and Adolescents’ Health.
The centrality of Reproductive, Maternal, Newborn, Child and Adolescent Health (RMNCAH) in the Agenda 2030, alongside the evolving global health architecture, provides the opportunity to reaffirm the crucial role of the UN agencies in supporting countries to improve the health and well-being of women, children and adolescents and address universal coverage with quality RMNCAH services, including adolescent sexual and reproductive health services.
In this respect, the six member organizations (UNAIDS, UNFPA, UNICEF, UN Women, WHO and the World Bank Group) of the partnership formerly known as the H4+ announced that the partnership renamed itself H6 to reflect the full commitment and engagement of the partners. It also reflects the broadened scope of the partnership to support countries to tackle the root causes of maternal, newborn, child and adolescent mortality and morbidity, including gender inequalities and sociocultural and financial barriers (the announcement is available here).
The members of the H6 will provide technical support to high-burden countries in their efforts to implement the UN Secretary-General’s Global Strategy for Women’s, Children’s and Adolescents’ Health 2016-2030 and reach the targets of the health-related Sustainable Development Goals.
The H6 is presently chaired by UNAIDS.
The Partnership for Maternal, Newborn & Child Health (The Partnership, PMNCH)
The Partnership for Maternal, Newborn & Child Health (PMNCH) is the world’s largest alliance for women’s, children’s and adolescents’ health. It brings together over 1,000 partner organizations from 10 constituencies across 192 countries.
PMNCH provides a platform for diverse organizations from donor agencies, national governments, the UN, academia, NGOs, the private sector, youth organizations and other groups to align objectives, strategies and resources, and to agree on evidence for action to support the attainment of the Sustainable Development Goals, including through Universal Health Coverage and Primary Health Care.
Visit the website
Global Financing Facility
Healthy women and children enable healthy economies, political stability and forward momentum. However, far too many newborns, children, adolescents and women still die of preventable conditions every year, and too few have access to quality health services.
The Global Financing Facility (GFF), in support of Every Woman Every Child, was announced in September 2014 to respond to this challenge and help close the funding gap for reproductive, maternal, newborn, child, and adolescent health.
Every Woman Every Child Innovation Marketplace
Despite progress under the Millennium Development Goals (MDGs), each year approximately 5.9 million children die before the age of five and 289,000 women die in pregnancy and childbirth. In the early years of life, 1 in 3 children fail to reach their full potential. The Sustainable Development Goals (SDGs) and a revised Global Strategy for Women’s, Children’s, and Adolescents’ Health have set targets to improve this situation. To meet those targets, innovation is required. Although there is an increasing number of Innovative healthcare concepts at the early pilot stage, a bottleneck exists at the “critical testing” ($250,000 – $2,000,000 to further prove a transformative concept) and “transition to scale” ($1,000,000 – $15,000,000) stage.
Response: EWEC Innovation Marketplace
To tackle this bottleneck, the Global Strategy for Women’s, Children’s and Adolescents’ Health has launched the Every Woman Every Child (EWEC) Innovation Marketplace. The Marketplace is a strategic alliance of development innovation organizations including the Bill and Melinda Gates Foundation, Grand Challenges Canada, the United States Agency for International Development, the Norwegian Agency for Development Cooperation and UBS Optimus Foundation.
The objective is to make 20 investments by 2020 and by 2030 to see at least 10 of these innovations widely available and having significant impact on women, children and adolescents.
To achieve these goals, the Marketplace pools the strengths of existing development innovation organizations to conduct curation and brokering.
Curation is comparative analysis of innovations sourced from partner organizations.
- The goal of curation is to identify the innovations in this pipeline of Marketplace partner innovations that show the most investment readiness and promise for impact on the health of women, children, and adolescents.
- All innovations considered in curation have already received past “proof-of- concept” funding from one or more Marketplace partners.
- The Marketplace has a strong advantage in identifying promising innovations, as it is able to assess information from across its partner organizations, including through platforms like the Innovation Exchange.
Brokering is the process of matching promising innovations to the right investor.
- The Marketplace brokers promising innovations to corporate, not-for-profit, governmental, and high-net-worth individual partners.
- The Marketplace also leverages broader networks of investors linked to the United Nations, for example: businesses which have made discretionary commitments to EWEC, and the country governments of the World Bank Global Financing Facility.
The Innovation Marketplace creates value by:
- Catalyzing investment in high quality innovations to improve women’s, children’s and adolescent’s health.
- Linking a supply of innovations from development innovation organizations to demand from companies and governments.
- Providing a mechanism for development innovation funders to source new deals and crowd-in co-funding for exciting projects.
- Addressing a lack of quality, vetted deal-flow in the healthcare innovation investment space.
- Convening stakeholders from the private sector, civil society, and government to help ease the pathway of innovations to scale.
Note: for more information on the “Innovation Marketplace”, including details of its pipeline, curation, brokering, and investment functions, please see the article “Innovating for Women’s, Children’s, and Adolescent’s Health” in the British Medical Journal.
To discuss the Innovation Marketplace, please contact the Innovation Marketplace Secretariat at email@example.com.
Independent Accountability Panel (IAP)
In September 2015, the UN Secretary-General launched the Every Woman Every Child Global Strategy for Women’s, Children’s and Adolescents’ Health to help further the 2030 Sustainable Development Goals (SDGs) Agenda. The strategy builds on 15 years of progress under the Millennium Development Goals and the Every Woman Every Child (EWEC) movement. A key strategic priority for EWEC is to ensure strong implementation of the SDGs.
To this end, the UN Secretary-General appointed the Every Woman Every Child’s Independent Accountability Panel (IAP). IAP’s vision is to provide an independent and transparent review of progress on the implementation of the Global Strategy and to identify and advocate the necessary actions to accelerate achievement of its goals from the accountability perspective, using as a starting point, the Strategy’s Indicator and Monitoring Framework. The IAP Terms of Reference are available here.
IAP is deeply committed to uncovering the root causes and to find solutions for the reduction of maternal and child deaths, so that we can meet the ambitious targets set by the new Global Strategy. IAP is committed to support the strengthening of national and sub-national accountability mechanisms and will rely upon their work to develop insights and recommendations.
As a result, the Panel produced its inaugural report: Old Challenges, New Hope in September 2016, during the 71st Session of the UN General Assembly. The report provided an independent assessment of progress and challenges to help strengthen the response from the international health community and countries. Since the first report, two additional reports have been launched at high-level events during the UN General Assembly in New York in 2017 and 2018: the 2017 Report Transformative Accountability for Adolescents and the 2018 Report on Private Sector: Who is Accountable?.
The IAP is preparing its 2020 report as its landmark report and, as requested by the Executive Office of the UN Secretary-General, one of the chapters will be dedicated to recommendations to strengthen health accountability (including independent accountability). The objective is to strengthen the accountability system for country impact and respond to the needs of women, children and adolescents and those left behind. In addition to reports, the IAP also issues statements, briefs, editorials on critical accountability issues. Please consult the IAP website: https://iapewec.org/ The IAP will carry forward the work of the Commission on Information and Accountability for Women’s and Children’s Health (CoIA). The CoIA produced 10 recommendations including the appointment of a nine member independent Expert Review Group (iERG), hosted by the World Health Organization (WHO). The iERG’s 2014 report and the Global Strategy call for the establishment of the IAP to carry forward the work of the iERG into the SDG era.
The IAP’s secretariat is independent, housed at PMNCH.
The IAP is comprised of the distinguished panelists below from diverse regions and backgrounds that range from human rights experts, to humanitarian leaders, to statisticians.
These panelists are empowered to command attention from the global community across the full range of the updated Global Strategy’s accountability framework—to monitor, review and act—and across the spectrum of issues that comprise the Global Strategy’s “Survive, Thrive, and Transform” themes.
In 2019, the external evaluation of the IAP was commissioned and managed under the oversight of the EWEC Secretariat/UNFPA Evaluation Office and conducted by Dr. Allison Beattie. The final report is available here.